Commonwealth-State Regulation Impact Statement – Department of Health
On 20 July 2021, the Gene Technology Ministers’ Meeting (GTMM), considered a Decision Regulation Impact Statement (Decision RIS) and endorsed the preferred option to address key recommendations of the Third Review of the National Gene Technology Scheme.
The RIS assessed options for delivering a more flexible, streamlined and risk-based regulatory process that future-proofs the Scheme, enables efficiencies, and relieves regulatory burden.